company background image
ALGN

Align Technology NasdaqGS:ALGN Stock Report

Last Price

US$293.06

Market Cap

US$23.1b

7D

3.6%

1Y

-57.3%

Updated

08 Aug, 2022

Data

Company Financials +
ALGN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

ALGN Stock Overview

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry.

Rewards

Trading at 11.2% below our estimate of its fair value

Earnings are forecast to grow 22.58% per year

Risk Analysis

ALGN passed our risk checks.

Align Technology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Align Technology
Historical stock prices
Current Share PriceUS$293.06
52 Week HighUS$737.45
52 Week LowUS$225.86
Beta1.78
1 Month Change12.06%
3 Month Change13.53%
1 Year Change-57.32%
3 Year Change63.10%
5 Year Change68.27%
Change since IPO1,592.77%

Recent News & Updates

Jul 27

Align Technology Non-GAAP EPS of $2.00 misses by $0.23, revenue of $969.55M misses by $16.5M

Align Technology press release (NASDAQ:ALGN): Q2 Non-GAAP EPS of $2.00 misses by $0.23. Revenue of $969.55M (-4.0% Y/Y) misses by $16.5M. Q2'22 operating income of $188.2 million and operating margin of 19.4%, which was unfavorably impacted by foreign exchange of approximately 1.1 points sequentially and approximately 2.4 points year over year. Purchased approximately 757 thousand shares of Align common stock at an average price of $264.37 per share for a total purchase price of $200.0 million. As of June 30, 2022, we had $977.2 million in cash, cash equivalents and short-term and long-term marketable securities compared to $1.1 billion as of March 31, 2022. In Q2'22, we purchased approximately 757 thousand shares of our common stock at an average price of $264.37 per share for a total purchase price of $200.0 million. Shares +0.15%.

Shareholder Returns

ALGNUS Medical EquipmentUS Market
7D3.6%2.4%1.1%
1Y-57.3%-21.3%-13.0%

Return vs Industry: ALGN underperformed the US Medical Equipment industry which returned -21.6% over the past year.

Return vs Market: ALGN underperformed the US Market which returned -12.9% over the past year.

Price Volatility

Is ALGN's price volatile compared to industry and market?
ALGN volatility
ALGN Average Weekly Movement7.5%
Medical Equipment Industry Average Movement9.8%
Market Average Movement7.9%
10% most volatile stocks in US Market17.1%
10% least volatile stocks in US Market3.2%

Stable Share Price: ALGN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ALGN's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199724,020Joe Hoganhttps://www.aligntech.com

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.

Align Technology, Inc. Fundamentals Summary

How do Align Technology's earnings and revenue compare to its market cap?
ALGN fundamental statistics
Market CapUS$23.09b
Earnings (TTM)US$619.03m
Revenue (TTM)US$3.99b

37.3x

P/E Ratio

5.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ALGN income statement (TTM)
RevenueUS$3.99b
Cost of RevenueUS$1.09b
Gross ProfitUS$2.90b
Other ExpensesUS$2.28b
EarningsUS$619.03m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Oct 26, 2022

Earnings per share (EPS)7.86
Gross Margin72.60%
Net Profit Margin15.52%
Debt/Equity Ratio0%

How did ALGN perform over the long term?

See historical performance and comparison